JVMSX | RSVAX | JVMSX / RSVAX | |
Total Expense Ratio | 1.24 | 1.30 | 95% |
Annual Report Gross Expense Ratio | 1.25 | 1.33 | 94% |
Fund Existence | 14 years | 32 years | - |
Gain YTD | 11.712 | 2.970 | 394% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 24.4B | 257M | 9,494% |
Annual Yield % from dividends | 0.40 | 0.37 | 109% |
Returns for 1 year | 2.46 | -4.37 | -56% |
Returns for 3 years | 23.90 | 6.24 | 383% |
Returns for 5 years | 52.77 | 27.26 | 194% |
Returns for 10 years | 54.59 | -16.54 | -330% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
IRSCX | 14.49 | 0.11 | +0.76% |
Macquarie Real Estate Securities C | |||
GSAHX | 16.67 | 0.09 | +0.54% |
Goldman Sachs Small Cap Growth Investor | |||
VESIX | 41.87 | 0.18 | +0.43% |
Vanguard European Stock Instl | |||
OARDX | 27.28 | -0.10 | -0.37% |
Invesco Rising Dividends A | |||
MXKJX | 8.67 | -0.04 | -0.47% |
Empower Mid Cap Value Instl |